iX Biopharma Ltd. (SGX:42C)

iX Biopharma Revenue

iX Biopharma had revenue of 3.71M SGD in the half year ending December 31, 2024, with 46.88% growth. This brings the company's revenue in the last twelve months to 7.00M, up 15.57% year-over-year. In the fiscal year ending June 30, 2024, iX Biopharma had annual revenue of 5.96M with 0.78% growth.

• Revenue (ttm): 7.00M
• Revenue Growth: +15.57%
• P/S Ratio: 2.34
• Revenue / Employee: 166.67K
• Employees: 42
• Market Cap: 17.67M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2024	5.96M	46.00K	0.78%
Jun 30, 2023	5.91M	-8.48M	-58.91%
Jun 30, 2022	14.39M	12.65M	724.64%
Jun 30, 2021	1.75M	760.00K	77.16%
Jun 30, 2020	985.00K	314.00K	46.80%